Amantadine Treatment for People with COVID-19
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference7 articles.
1. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial;Gautret;Int J Antimicrob Agents,2020
2. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. [letter];Molina;Med Mal Infect,2020
3. Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial;Borba;JAMA Netw Open,2020
4. Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment;Rejdak;Mult Scler Relat Disord,2020
5. Amantadine disrupts lysosomal gene expression: a hypothesis for COVID19 treatment;Smieszek;Int J Antimicrob Agents,2020
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Amantadine interactions with phase separated lipid membranes;Chemistry and Physics of Lipids;2024-08
2. Drug Nanocrystals: A Delivery Channel for Antiviral Therapies;AAPS PharmSciTech;2024-02-17
3. Nanomedicine Formulation Using Green Supercritical Processing: Experimental Solubility Measurement and Theoretical Investigation;Chemical Engineering & Technology;2023-11-02
4. Effects of defoliant exposure and medication use on the development of Parkinson’s disease in veterans;Age and Ageing;2023-10-02
5. Amantadine for COVID-19 treatment (ACT) study: a randomized, double-blinded, placebo-controlled clinical trial;Clinical Microbiology and Infection;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3